Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $95,781 | 76 | 64.0% |
| Food and Beverage | $22,985 | 1,103 | 15.4% |
| Consulting Fee | $17,153 | 8 | 11.5% |
| Travel and Lodging | $12,889 | 56 | 8.6% |
| Honoraria | $500.00 | 1 | 0.3% |
| Education | $225.96 | 36 | 0.2% |
| Gift | $59.40 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $52,771 | 171 | $0 (2022) |
| Lilly USA, LLC | $40,344 | 104 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $31,282 | 86 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $8,129 | 44 | $0 (2024) |
| Novo Nordisk Inc | $2,133 | 169 | $0 (2024) |
| Medtronic MiniMed, Inc. | $1,599 | 22 | $0 (2020) |
| Medtronic, Inc. | $1,212 | 46 | $0 (2024) |
| Amgen Inc. | $1,140 | 63 | $0 (2024) |
| Amarin Pharma Inc. | $1,058 | 80 | $0 (2023) |
| PFIZER INC. | $1,020 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,303 | 174 | Lilly USA, LLC ($9,999) |
| 2023 | $7,436 | 132 | Boehringer Ingelheim Pharmaceuticals, Inc. ($4,362) |
| 2022 | $10,073 | 176 | Boehringer Ingelheim Pharmaceuticals, Inc. ($5,831) |
| 2021 | $6,688 | 143 | AstraZeneca Pharmaceuticals LP ($4,871) |
| 2020 | $13,175 | 137 | Lilly USA, LLC ($4,007) |
| 2019 | $20,119 | 210 | AstraZeneca Pharmaceuticals LP ($6,897) |
| 2018 | $29,095 | 132 | AstraZeneca Pharmaceuticals LP ($13,832) |
| 2017 | $49,704 | 177 | AstraZeneca Pharmaceuticals LP ($22,499) |
All Payment Transactions
1,281 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: Diabetes Care | ||||||
| 12/12/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: Durable Pump | ||||||
| 12/10/2024 | Lilly USA, LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $350.00 | General |
| 12/10/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $8.56 | General |
| 11/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Cardio-renal | ||||||
| 11/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Bone Health | ||||||
| 11/21/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: Durable Pump | ||||||
| 11/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $9.26 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $61.03 | General |
| Category: Durable Pump | ||||||
| 11/14/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $60.35 | General |
| Category: Durable Pump | ||||||
| 11/14/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $55.97 | General |
| Category: Durable Pump | ||||||
| 11/14/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $7.19 | General |
| Category: Durable Pump | ||||||
| 11/14/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $2.65 | General |
| Category: Durable Pump | ||||||
| 11/12/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/06/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $11.23 | General |
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: Cardio-renal | ||||||
| 11/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $6.14 | General |
| Category: Cardiology | ||||||
| 10/24/2024 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $24.03 | General |
| 10/21/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Durable Pump | ||||||
| 10/15/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $139.93 | General |
| Category: Cardio-renal | ||||||
| 10/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: Diabetes Care | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,204 | 4,534 | $624,086 | $185,327 |
| 2022 | 11 | 1,518 | 12,565 | $904,733 | $333,702 |
| 2021 | 12 | 1,915 | 14,192 | $940,910 | $399,522 |
| 2020 | 13 | 1,906 | 13,426 | $857,559 | $342,449 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 334 | 661 | $257,132 | $83,216 | 32.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 42 | 2,580 | $74,820 | $44,970 | 60.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 205 | 348 | $160,481 | $28,564 | 17.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 51 | 51 | $32,074 | $8,436 | 26.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 98 | 225 | $31,620 | $5,902 | 18.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 165 | 253 | $14,741 | $3,306 | 22.4% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 42 | 42 | $17,918 | $3,272 | 18.3% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 22 | 25 | $8,089 | $2,770 | 34.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 174 | 272 | $11,924 | $2,580 | 21.6% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 12 | 12 | $8,882 | $1,294 | 14.6% |
| 10006 | Fine needle aspiration biopsy using ultrasound guidance, each additional growth | Office | 2023 | 12 | 12 | $1,560 | $573.72 | 36.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 47 | 53 | $4,844 | $442.94 | 9.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 104 | 10,140 | $294,060 | $171,607 | 58.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 320 | 624 | $242,585 | $80,707 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 320 | 573 | $205,449 | $47,154 | 23.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 65 | 65 | $41,960 | $9,858 | 23.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 83 | 195 | $27,600 | $5,252 | 19.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 211 | 336 | $19,626 | $4,395 | 22.4% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 52 | 52 | $22,180 | $3,992 | 18.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 209 | 344 | $15,020 | $3,274 | 21.8% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 22 | 25 | $8,045 | $2,999 | 37.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $10,659 | $2,271 | 21.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 113 | 192 | $17,549 | $2,193 | 12.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 115 | 10,989 | $241,020 | $176,156 | 73.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 306 | 639 | $204,473 | $84,776 | 41.5% |
About Dr. Molouk Rahnema, MD
Dr. Molouk Rahnema, MD is a Specialist healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1598968000.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Molouk Rahnema, MD has received a total of $149,593 in payments from pharmaceutical and medical device companies, with $13,303 received in 2024. These payments were reported across 1,281 transactions from 61 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($95,781).
As a Medicare-enrolled provider, Rahnema has provided services to 6,543 Medicare beneficiaries, totaling 44,717 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location Las Vegas, NV
- Active Since 06/11/2007
- Last Updated 07/10/2023
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1598968000
Products in Payments
- FARXIGA (Drug) $47,905
- JARDIANCE (Drug) $46,662
- BASAGLAR (Drug) $11,273
- SOLIQUA (Drug) $7,579
- BYDUREON (Drug) $4,770
- Minimed 670G System (Device) $1,401
- MINIMED 780G (Device) $1,065
- Vascepa (Drug) $1,058
- Ozempic (Drug) $1,040
- SOMAVERT (Drug) $1,020
- SYNTHROID (Drug) $527.04
- Kerendia (Drug) $513.91
- Tymlos (Biological) $487.96
- JANUVIA (Drug) $470.76
- Repatha (Biological) $443.81
- EVENITY (Biological) $425.11
- FREESTYLE LIBRE 3 (Device) $384.17
- AFREZZA (Drug) $360.82
- Korlym (Drug) $359.55
- Rybelsus (Drug) $359.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Las Vegas
Dr. Mehdi Ansarinia, Md, MD
Specialist — Payments: $347,145
George Kelly, Md, MD
Specialist — Payments: $305,649
Dr. Galen Kam, M.d, M.D
Specialist — Payments: $184,471
Dr. Steven Leibowitz, M.d, M.D
Specialist — Payments: $135,214
Edward Zimmerman, M.d, M.D
Specialist — Payments: $98,329
Mr. Stephen Miller, M.d., F.a.c.s, M.D., F.A.C.S
Specialist — Payments: $69,582